BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28000363)

  • 21. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
    Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
    J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X; Kumar RA; Patel DJ
    Chem Biol; 1995 Dec; 2(12):827-40. PubMed ID: 8807816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA.
    Kamine J; Loewenstein P; Green M
    Virology; 1991 Jun; 182(2):570-7. PubMed ID: 2024489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.
    Neenhold HR; Rana TM
    Biochemistry; 1995 May; 34(19):6303-9. PubMed ID: 7756257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues.
    Naryshkin NA; Farrow MA; Ivanovskaya MG; Oretskaya TS; Shabarova ZA; Gait MJ
    Biochemistry; 1997 Mar; 36(12):3496-505. PubMed ID: 9131999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.
    Dingwall C; Ernberg I; Gait MJ; Green SM; Heaphy S; Karn J; Lowe AD; Singh M; Skinner MA
    EMBO J; 1990 Dec; 9(12):4145-53. PubMed ID: 2249668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1.
    Zhang J; Tamilarasu N; Hwang S; Garber ME; Huq I; Jones KA; Rana TM
    J Biol Chem; 2000 Nov; 275(44):34314-9. PubMed ID: 10944537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking.
    Liu Y; Wang Z; Rana TM
    J Biol Chem; 1996 Apr; 271(17):10391-6. PubMed ID: 8626612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.